Myeloma XI Quadruplet regimen for transplant eligible patients shows promise

Myeloma XI: Quadruplet regimen for transplant eligible patients shows promise

11:57 EST 17 Dec 2018 | ecancermedicalscience

Hope has emerged for patients with a serious type of bone marrow cancer as new research into a therapeutic drug has revealed improved outcomes and survival rates. In the largest study of its kind, researchers at Newcastle University, UK, have led...

More From BioPortfolio on "Myeloma XI: Quadruplet regimen for transplant eligible patients shows promise"